10 March 2026

Exclusive Interview: Dr Ee Xien Ng, Technical Expert, APAC, BioReliance® Contract Testing Services, Advanced Solutions, Merck Life Science | ADC Asia Congress 2026

Dr. Ee Xien Ng from Merck explains how Next-Generation Sequencing (NGS) is enabling deeper genomic insights to support safer biomanufacturing decisions, helping complex modalities such as ADCs move confidently toward GMP manufacturing while keeping pace with evolving regulatory expectations.

Download the Full White Paper Here!

Download the Full e-Book Here!

Download

Download the Full Interview Here!

Download
Exclusive Interview: Dr Ee Xien Ng, Technical Expert, APAC, BioReliance® Contract Testing Services, Advanced Solutions, Merck Life Science | ADC Asia Congress 2026

Complete the Form to get Full Access the Webinar Video

Thank you! Click below to view/download:
Oops! Something went wrong while submitting the form.

Subscribe For News Updates

Subscribe to the IMAPAC Newsletter to stay informed of the latest news in the biopharmaceutical industry.

By clicking Sign Up you're confirming that you agree with our Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
WeChat